Sponsor Pipeline

SURGE Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-23 NCT07723469 Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07723469 Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing… TNBC - Triple-Negative Breast Cancer Not Yet Recruiting
Phase 1/2
NCT05710848 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer Non-muscle-invasive Bladder Cancer Recruiting
Phase 1
NCT06450106 Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy Prostate Cancer Recruiting
Disease Areas
Bladder Cancer (1) Prostate Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when SURGE Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free